Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial

Maria Molina-Molina,Jessica Germaine Shull,Vanesa Vicens-Zygmunt, Pilar Rivera-Ortega,Katerina Antoniou,Francesco Bonella,Elisabetta Renzoni,Anne-Marie Russell,Toby M. Maher,Ada Vancheri,Anna Bachs, Victoria Aviles,Josep Palma,Guadalupe Bermudo,Guillermo Suarez-Cuartin,Cristian Tebe,Raul Rigo-Bonnin,Ana Montes-Worboys,Marlies Wijsenbeek,Carlo Vancheri

The European respiratory journal（2023）

引用 0|浏览17

暂无评分

摘要

Tweetable abstract

Individuals with IPF who follow a MUFA diet report a lower incidence of pirfenidone gastrointestinal adverse events than those that follow a SFA diet, which could explain the different prevalence in GI pirfenidone AEs reported by countries in IPF cohortshttps://bit.ly/3LuzAUJ

查看译文

关键词

gastrointestinal pirfenidone,idiopathic pulmonary fibrosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要